Ehrenberg Miriam, Avraham Maayan, Asodu Sandeep Sarma, Moye Abigail R, Sangermano Riccardo, Rizel Leah, Ali-Nasser Tahleel, Sher Ifat, Gurwitz David, Chao Katherine R, Rivera Antonio, Webster Andrew R, Rivolta Carlo, Newman Hadas, Pras Eran, Rotenstreich Ygal, Banin Eyal, Pierce Eric A, Zur Dinah, Arno Gavin, Bujakowska Kinga M, Lin Siying, Sharon Dror, Ben-Yosef Tamar
Department of Ophthalmology, Schneider Children's Medical Center of Israel, Petach Tikva, Israel; Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel.
The Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
Genet Med. 2025 Jun;27(6):101401. doi: 10.1016/j.gim.2025.101401. Epub 2025 Mar 10.
To identify the genetic cause for disease in individuals affected with inherited retinal disease and to characterize their retinal phenotype and the properties of the underlying gene.
Participants underwent a comprehensive ophthalmological evaluation, including best-corrected visual acuity, visual field testing, fundus autofluorescence, optical coherence tomography, and electroretinography. Genetic analyses included exome, genome, and Sanger sequencing. Gene expression pattern was analyzed by reverse transcription-polymerase chain reaction. Localization of the encoded protein in cells and in the human retina was examined by immunofluorescence staining.
Four different pathogenic variants in C19orf44 were identified in 15 biallelic individuals from 11 unrelated families. The most common variant was c.549_550del p.(Ser185ProfsTer2). Most individuals were affected with a unique clinical phenotype characterized by late-onset patchy perifoveal chorioretinal atrophy and electroretinographic features of rod-cone degeneration. C19orf44 is expressed in various human tissues, including the retina, where it was found in the outer nuclear layer and in the outer plexiform layer. In cultured cells (hTERT RPE-1 and HeLa) and in human primary fibroblasts, C19orf44 is found in the nucleus, and it is downregulated during mitosis.
Based on our results, C19orf44 is crucial for normal human retinal function, and pathogenic variants in this gene are associated with autosomal recessive inherited retinal disease.
确定患有遗传性视网膜疾病个体的疾病遗传病因,并描述其视网膜表型及相关基因的特性。
参与者接受了全面的眼科评估,包括最佳矫正视力、视野测试、眼底自发荧光、光学相干断层扫描和视网膜电图检查。基因分析包括外显子组、基因组和桑格测序。通过逆转录-聚合酶链反应分析基因表达模式。通过免疫荧光染色检查编码蛋白在细胞和人视网膜中的定位。
在来自11个无关家庭的15名双等位基因个体中鉴定出C19orf44基因的四种不同致病变体。最常见的变体是c.549_550del p.(Ser185ProfsTer2)。大多数个体患有独特的临床表型,其特征为迟发性黄斑周围散在性脉络膜视网膜萎缩以及视杆-视锥细胞变性的视网膜电图特征。C19orf44在包括视网膜在内的多种人体组织中表达,在视网膜的外核层和外网状层中被发现。在培养细胞(hTERT RPE-1和HeLa)和人原代成纤维细胞中,C19orf44存在于细胞核中,并且在有丝分裂期间表达下调。
基于我们的研究结果,C19orf44对正常人类视网膜功能至关重要,该基因的致病变体与常染色体隐性遗传性视网膜疾病相关。